Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17394846 | 0.79 | — | — | |
| SCHEMBL10646120 | 0.76 | CYP19A1 (0.43) | CYP19A1LMNATSHRCYP1B1 | |
| SCHEMBL9418499 | 0.74 | CYP19A1 (0.40) | CYP19A1MEN1KMT2ALMNATSHR | |
| SCHEMBL4166949 | 0.74 | KMT2A (0.41) | CYP19A1MEN1KMT2ALMNATSHR | |
| SCHEMBL9418494 | 0.74 | CYP19A1 (0.40) | CYP19A1MEN1KMT2ALMNATSHR | |
| SCHEMBL8831809 | 0.69 | CYP19A1 (0.31) | CYP19A1LMNATSHR | |
| SCHEMBL21544609 | 0.69 | CYP19A1 (0.33) | CYP19A1MEN1KMT2ALMNATSHR | |
| SCHEMBL15308966 | 0.69 | LMNA (0.38) | CYP19A1MEN1KMT2ALMNATSHR | |
| SCHEMBL13261222 | 0.66 | CYP19A1 (0.53) | CYP19A1LMNATSHR | |
| SCHEMBL178322 | 0.66 | CYP19A1 (0.53) | CYP19A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475256-B1 | DEHYDROGENATION REACTION | FIRMENICH & CIE (CH) | 2024-01-24 | — | — | EP | claimed |
| CN-109415293-B | Dehydrogenation reaction | 弗门尼舍有限公司 | 2022-08-02 | — | — | CN | claimed |
| US-10899694-B2 | Dehydrogenation reaction | FIRMENICH SA (CH) | 2021-01-26 | — | — | US | claimed |
| US-20190345088-A1 | DEHYDROGENATION REACTION | FIRMENICH SA (CH) | 2019-11-14 | — | — | US | claimed |
| EP-1926698-B1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH & CIE (CH) | 2016-03-09 | — | — | EP | claimed |
| US-7704933-B2 | α-Decalones with damascone-woody odor | FIRMENICH SA (CH) | 2010-04-27 | — | — | US | claimed |
| US-20080214433-A1 | Alpha-Decalones with Damascone-Woody Odor | FIREMENICH SA (CH) | 2008-09-04 | — | — | US | claimed |
| EP-1926698-A1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH SA (CH) | 2008-06-04 | — | — | EP | claimed |
| WO-2007031904-A1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH SA (CH) | 2007-03-22 | — | — | WO | claimed |
| EP-3475256-B1 | DEHYDROGENATION REACTION | FIRMENICH & CIE (CH) | 2024-01-24 | — | — | EP | disclosed |
| EP-3475256-B1 | DEHYDROGENATION REACTION | FIRMENICH & CIE (CH) | 2024-01-24 | — | — | EP | disclosed |
| CN-109415293-B | Dehydrogenation reaction | 弗门尼舍有限公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-3164377-B1 | PRINS REACTION ON HINDERED SUBSTRATES | FIRMENICH & CIE (CH) | 2022-06-08 | — | — | EP | disclosed |
| US-10899694-B2 | Dehydrogenation reaction | FIRMENICH SA (CH) | 2021-01-26 | — | — | US | disclosed |
| EP-1926698-B1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH & CIE (CH) | 2016-03-09 | — | — | EP | disclosed |
| WO-2016001286-A1 | PRINS REACTION ON HINDERED SUBSTRATES | FIRMENICH SA (CH) | 2016-01-07 | — | — | WO | disclosed |
| US-7704933-B2 | α-Decalones with damascone-woody odor | FIRMENICH SA (CH) | 2010-04-27 | — | — | US | disclosed |
| US-20080214433-A1 | Alpha-Decalones with Damascone-Woody Odor | FIREMENICH SA (CH) | 2008-09-04 | — | — | US | disclosed |
| EP-1926698-A1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH SA (CH) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007031904-A1 | ALPHA-DECALONES WITH DAMASCONE-WOODY ODOR | FIRMENICH SA (CH) | 2007-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10899694-B2 | Dehydrogenation reaction | PDK3, PDK2, PDHA1 | CYP19A1 185/4885MEN1 789/4885KMT2A 2831/4885 |
| US-20190345088-A1 | DEHYDROGENATION REACTION | PDK3, PDK2, PDHA1 | CYP19A1 185/4885MEN1 789/4885KMT2A 2831/4885 |
| US-20080214433-A1 | Alpha-Decalones with Damascone-Woody Odor | DPM1, DAD1, DECR1 | CYP19A1 2761/4885MEN1 3439/4885KMT2A 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.